Chesapeake Capital Corp IL Makes New Investment in Corteva, Inc. $CTVA

Chesapeake Capital Corp IL bought a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 17,874 shares of the company’s stock, valued at approximately $1,209,000. Corteva accounts for 1.1% of Chesapeake Capital Corp IL’s investment portfolio, making the stock its 17th biggest position.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Activest Wealth Management grew its stake in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after buying an additional 200 shares in the last quarter. True Wealth Design LLC lifted its stake in Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after acquiring an additional 264 shares during the last quarter. Total Investment Management Inc. bought a new stake in Corteva in the second quarter worth approximately $27,000. Twin Peaks Wealth Advisors LLC bought a new stake in Corteva in the second quarter worth approximately $29,000. Finally, Redmont Wealth Advisors LLC acquired a new position in shares of Corteva during the 3rd quarter worth $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

CTVA opened at $79.13 on Friday. The firm has a market capitalization of $53.22 billion, a P/E ratio of 50.08, a price-to-earnings-growth ratio of 2.73 and a beta of 0.72. The stock’s 50 day moving average price is $74.11 and its two-hundred day moving average price is $69.24. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $80.90.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same period in the prior year, the company earned $0.32 EPS. The business’s quarterly revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.18 per share. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio is 45.57%.

Wall Street Analysts Forecast Growth

CTVA has been the subject of several recent analyst reports. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Oppenheimer set a $86.00 price objective on Corteva in a research note on Thursday, February 5th. Mizuho boosted their target price on Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a report on Tuesday, February 17th. JPMorgan Chase & Co. cut Corteva from an “overweight” rating to a “neutral” rating and upped their target price for the stock from $75.00 to $77.00 in a research report on Thursday, February 5th. Finally, Argus upgraded Corteva to a “strong-buy” rating in a report on Friday, January 16th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and an average price target of $82.90.

Insiders Place Their Bets

In other news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.14% of the stock is owned by corporate insiders.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.